The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success.
Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸
Get your unique referral link here: refer.excedr.com/ZTHETY.
Show Notes
Part 1 of 2: Our guest today is Kate Yen, Founder and CEO of Auron Therapeutics.
Auron Therapeutics leverages cutting-edge science and AI-powered analysis to develop next-generation cancer therapies by mapping key drivers of tumorigenesis.
Kate earned her Ph.D. in Biological Chemistry from UCLA, where she also completed her postdoc. She held roles at Merck and as a UCLA professor before joining Agios Pharmaceuticals, where she led the IDH translational research team behind two FDA-approved IDH mutant inhibitors and co-led the discovery of vorasidenib, a promising glioma therapy now in clinical development.
With deep expertise in preclinical and clinical research, a proven track record in advancing breakthrough therapies, and a passion for oncology, Kate’s journey and insights are invaluable.
In this episode, you'll hear about:
- Kate Yen’s journey from aspiring physician to PhD researcher at UCLA
- How her postdoc in Charles Sawyers’ lab sparked her passion for translational research
- Transitioning from academia to industry and learning drug discovery at Merck
- Taking the leap to join Agios Pharmaceuticals and leading the IDH program
- The role of collaboration in biotech, from academia to CRO partnerships
If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening.
Resources & Articles
Auron Therapeutics: https://www.aurontx.com/
Merck: https://www.merck.com/
Agios Pharmaceuticals: https://www.agios.com/
UCLA: https://www.ucla.edu/
Princeton University: https://www.princeton.edu/
Biotech Startup Fundraising: https://www.excedr.com/resources/biotech-startup-funding-options
Biotech Accelerators: https://www.excedr.com/resources/biotech-accelerators
Biotech Incubators: https://www.excedr.com/resources/biotech-incubators
Top VC Firms for Biotech: https://www.excedr.com/blog/top-vc-firms-for-biotech
50 Biotech Seed & Angel Investors: https://www.excedr.com/blog/biotech-seed-and-angel-investors
Guide to Choosing a CRO: https://www.excedr.com/blog/contract-research-organizations
Guide to Choosing a CMO: https://www.excedr.com/blog/contract-manufacturing-organizations
Organizations & People
Charles Sawyers: https://en.wikipedia.org/wiki/Charles_Sawyers
Lew Cantley: https://en.wikipedia.org/wiki/Lewis_C._Cantley
David Schenkein: https://www.linkedin.com/in/david-schenkein-md-45342476/
Mike Carey: https://www.uclahealth.org/cancer/members/michael-carey